AMERICAN SHARED HOSPITAL SERVICES Accounts Payable
AMERICAN SHARED HOSPITAL SERVICES (AMS) had Accounts Payable of $582.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $582.00K.
- 2026-03-31: Accounts Payable, Current $1.08M.
- 2025-12-31: Accounts Payable, Current $607.00K.
- 2025-09-30: Accounts Payable, Current $1.11M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $582.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.08M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $607.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $1.11M 10-Q/A · filed 2026-01-16 | |
| 2025-06-30 | $806.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $1.23M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.56M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $1.79M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $859.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $267.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $315.00K 10-K · filed 2025-04-04 | |
| 2023-09-30 | $346.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $297.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $254.00K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $230.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $270.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $145.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $396.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $318.00K 10-K · filed 2023-03-31 | $746.00K 10-K · filed 2022-03-30 |
| 2021-09-30 | $277.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $584.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $885.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $683.00K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $898.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $1.13M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $851.00K 10-Q/A · filed 2020-06-11 | |
| 2019-12-31 | $557.00K 10-K · filed 2021-04-06 | |
| 2019-09-30 | $1.10M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $446.00K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $446.00K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $435.00K 10-K · filed 2020-04-03 | |
| 2018-09-30 | $554.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $411.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $724.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $359.00K 10-K · filed 2019-03-29 | |
| 2017-09-30 | $261.00K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $206.00K 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $437.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $319.00K 10-K · filed 2018-03-28 | |
| 2016-09-30 | $297.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $218.00K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $531.00K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $375.00K 10-K · filed 2017-03-27 | |
| 2015-09-30 | $454.00K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $289.00K 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $301.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $421.00K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $348.00K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $575.00K 10-Q · filed 2014-08-15 | |
| 2014-03-31 | $895.00K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $572.00K 10-K · filed 2015-04-01 | |
| 2013-09-30 | $867.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $918.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $434.00K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $263.00K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $260.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $211.00K 10-Q/A · filed 2012-09-07 | |
| 2012-03-31 | $283.00K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $278.00K 10-K · filed 2013-03-29 | |
| 2011-09-30 | $144.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $153.00K 10-Q/A · filed 2011-10-24 | |
| 2010-12-31 | $337.00K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |